Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.855
-0.055 (-2.88%)
At close: Sep 25, 2026, 4:00 PM EDT
1.890
+0.035 (1.89%)
After-hours: Sep 25, 2026, 7:59 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $493.73 million as of September 25, 2026. Its market cap has increased by 18.91% in one year.
Market Cap
493.73M
Enterprise Value
659.91M
1-Year Change
18.91%
Ranking
Category
Stock Price
$1.86
ChartMarket Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $944.40M to $493.73M, a decrease of -47.72%. That is a compound annual growth rate of -7.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 493.70M | -6.78% |
| Dec 31, 2025 | 529.60M | -15.32% |
| Dec 31, 2024 | 625.40M | -44.19% |
| Dec 29, 2023 | 1.12B | 546.94% |
| Dec 30, 2022 | 173.20M | -54.23% |
| Dec 31, 2021 | 378.40M | -19.08% |
| Dec 31, 2020 | 467.60M | -21.25% |
| Dec 31, 2019 | 593.80M | -54.96% |
| Dec 31, 2018 | 1.32B | 39.60% |
| Jun 22, 2018 | 944.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 535.72M |
| Indaptus Therapeutics | 532.97M |
| AgomAb Therapeutics NV | 521.04M |
| Arvinas | 509.36M |
| ProKidney | 507.90M |
| Puma Biotechnology | 506.91M |
| Capricor Therapeutics | 498.25M |
| Ovid Therapeutics | 487.27M |